Genenta Science S.p.A. (GNTA): R&D Expense

Annual figures by period end, from SEC filings.

2.70M EUR
Year ended 2025-12-31
-20.3%
3-year compound annual growth
-10.5%
5-year compound annual growth
6.47M EUR2019-12-31: 3.70M EUR2020-12-31: 4.69M EUR2021-12-31: 3.39M EUR2022-12-31: 5.34M EUR2023-12-31: 6.47M EUR2024-12-31: 4.81M EUR2025-12-31: 2.70M EUR2.70M EUR
2019-12-31 R&D Expense (EUR) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-312.70M EUR-43.9%2026-04-01, From 2025-01-01
2024-12-314.81M EUR-25.7%2026-04-01, From 2024-01-01
2023-12-316.47M EUR+21.3%2026-04-01, From 2023-01-01
2022-12-315.34M EUR+57.5%2025-03-28, From 2022-01-01
2021-12-313.39M EUR-27.7%2024-03-29, From 2021-01-01
2020-12-314.69M EUR+26.6%2023-04-21, From 2020-01-01
2019-12-313.70M EURn/a2022-05-02, From 2019-01-01